Badger Meter stock rating held at Outperform by RBC Capital

RBC Capital kept an Outperform rating on Badger Meter but maintained a $197 price target while warning of a negative mid- to high-teens relative underperformance after management lowered 2026 outlook. The stock is down 12.5% YTD, trading at $127.29, nearly 50% below its 52-week high of $256.08, and near its 52-week low amid elevated short interest. Recent Q4 results missed estimates on both EPS ($1.14 vs. $1.16) and revenue ($220.7M vs. $231.98M), though the company also announced a $100M acquisition and a larger $150M share repurchase authorization.

Analysis

BMI looks like a classic guidance-reset trade where the fundamental damage is likely less severe than the price action implies, but the market is still forced sellers until confidence in the next few quarters stabilizes. The key second-order effect is not just lower estimates; it is a likely compression in multiple as the market stops paying for execution certainty and starts valuing the stock more like a cyclical industrial with project timing risk. That said, the combination of buybacks, dividend discipline, and an accretive tuck-in acquisition gives management multiple tools to cushion downside if the demand gap is timing rather than structural.

The cleaner winner on a relative basis may be Xylem, but the read-through is asymmetric: any weakness there is probably a sentiment event, not a balance-sheet or end-market problem. If BMI’s issues are mostly AMI schedule slippage, then peers exposed to the same channel should see only modest estimate drift; the bigger risk is that investors extrapolate one company’s timing issues into a broader water infrastructure slowdown. That creates an opportunity for relative-value positioning rather than outright sector de-risking.

The setup still feels bearish for a few weeks because elevated short interest can prolong underperformance, especially when a stock is near the low end of its historical valuation band and there is no near-term catalyst to force covering. But over a 3-6 month horizon, the catalyst path is clearer: order normalization, a cleaner 2026 setup, and capital return support can re-rate the stock back toward the mid-range multiple if management avoids another cut. The contrarian case is that the market is already pricing a recessionary outcome for a business that may simply be lumpy, and that distinction matters for entry timing.

Key Decisions for Investors

• Long BMI on weakness only: start a 25-50% starter position if it trades another 5-7% lower, with a 3-6 month horizon and upside back toward the high-teens percent underperformance gap closing as estimates stabilize.
• Use a BMI call spread instead of stock for the next catalyst window: buy 3-6 month ATM/OTM calls and finance with a farther OTM short call to express a rebound from forced-selling exhaustion with defined risk.
• Pair trade: long XYL / short BMI for the next 4-8 weeks if you want to isolate water-infrastructure quality versus estimate-reset risk; the spread should benefit if BMI’s short interest keeps pressure on the tape.
• Do not add aggressively until management commentary confirms AMI timing normalization; if the next print or update shows no further guide-down, cover shorts or take profits on bearish exposure quickly.
• For event-driven accounts, sell puts on BMI 10-15% below spot into elevated implied volatility to harvest premium while waiting for capitulation to clear.